News | January 03, 2024
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Subscribe To Our Newsletter & Stay Updated
